Literature DB >> 25362716

Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group.

April W Armstrong1, William Tuong2, Thorvardur J Love2, Sueli Carneiro2, Rachel Grynszpan2, Steve S Lee2, Arthur Kavanaugh2.   

Abstract

Nail involvement in psoriatic diseases causes significant physical and functional disabilities. Evaluating, measuring, and treating nail involvement is important in improving the health outcomes and quality of life among patients with psoriasis and psoriatic arthritis (PsA). We performed a systematic analysis of the literature on nail psoriasis to help inform an update of treatment recommendations by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Entities:  

Keywords:  EFFECTIVENESS; EFFICACY; NAIL PSORIASIS; PSORIASIS; THERAPY; TREATMENT

Mesh：

Substances：

Year:  2014        PMID： 25362716     DOI： 10.3899/jrheum.140881

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Authors:  F Behrens; D Thaçi; J Wollenhaupt; K Krüger
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

2.  Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.

Authors:  Peter Foley; Kenneth Gordon; Christopher E M Griffiths; Yasmine Wasfi; Bruce Randazzo; Michael Song; Shu Li; Yaung-Kaung Shen; Andrew Blauvelt
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

Review 3.  [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Authors:  F Behrens; D Thaçi; J Wollenhaupt; K Krüger
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

4.  Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study.

Authors:  Yukari Okubo; Hidetoshi Takahashi; Ryosuke Hino; Koki Endo; Satoru Kikuchi; Yasushi Ozeki; Taichi Nakamura; Maria Paris; Masatoshi Abe
Journal:  Dermatol Ther (Heidelb)       Date:  2022-06-11

5.  Efficacy of Biologics Targeting Tumour Necrosis Factor-alpha, Interleukin-17 -12/23, -23 and Small Molecules Targeting JAK and PDE4 in the Treatment of Nail Psoriasis: A Network Meta-analysis.

Authors:  Júlia Szebényi; Noémi Gede; Péter Hegyi; Zsolt Szakács; Margit Solymár; Bálint Erőss; András Garami; Kornélia Farkas; Dezső Csupor; Rolland Gyulai
Journal:  Acta Derm Venereol       Date:  2020-11-12       Impact factor: 3.875

6.  A Case of Nail Psoriasis Successfully Treated with Intralesional Methotrexate.

Authors:  Sana Mokni; Khaoula Ameur; Najet Ghariani; Badreddine Sriha; Colandane Belajouza; Mohamed Denguezli; Rafiaa Nouira
Journal:  Dermatol Ther (Heidelb)       Date:  2018-09-25

7.  Treatment guidelines in psoriatic arthritis.

Authors:  Alexis Ogdie; Laura C Coates; Dafna D Gladman
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.